10
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12155 |
Y1 receptor antagonist 1
H 409-22 isomer |
Others | Others |
Y1 receptor antagonist 1 is an antagonist of neuropeptide Y1 receptor. | |||
T74350 |
Neuropeptide Y Y1 receptor antagonist 1
|
||
Neuropeptide Y Y1 receptor antagonist 1 (化合物 39),一种荧光探针,是神经肽 Y Y1受体 (Y1R) 的拮抗剂,Ki 值为 0.19 nM。储存方式:避光。 | |||
T22608 |
BMS 193885
BMS193885 |
Neuropeptide Y Receptor | GPCR/G Protein; Neuroscience |
BMS 193885 是一种选择性和竞争性神经肽 Y(1) 受体拮抗剂,亲和力为 3.3 nM。 | |||
T26855 |
BMS-665053
BMS665053 |
||
BMS-665053 is a corticotropin-releasing factor-1 (CRF1) receptor antagonist (IC50 = 1.0 nM). BMS-665053)11 is a potent inhibitor of CRF-stimulated cyclic adenosine monophosphate (cAMP) production in human Y-79 retinoblastoma cells (IC50 = 4.9 nM). In addi | |||
T76357 |
Neuropeptide Y (18-36) (porcine)
|
||
Neuropeptide Y (18-36) (porcine) 是一种与Neuropeptide Y(NPY)心脏受体进行竞争性拮抗的化合物。该化合物通过浓度依赖的方式,抑制I-NPY与心室膜的结合,具有IC50值158 nM和Ki值140 nM。Neuropeptide Y (18-36) (porcine) 主要用于充血性心力衰竭的研究。 | |||
T36662 |
Imidafenacin Metabolite M4
Imidafenacin Metabolite M4 |
||
Imidafenacin metabolite M4 is a metabolite of the muscarinic acetylcholine receptor antagonist imidafenacin.1It is formed from imidafenacin by the cytochrome P450 (CYP) isoform CYP3A4. 1.Kanayama, N., Kanari, C., Masuda, Y., et al.Drug-drug interactions in the metabolism of imidafenacin: Role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymesXenobiotica37(2)139-154(2007) | |||
T75910 |
GR231118 TFA
|
||
GR231118是神经肽Y的C末端类似物,作为人神经肽YY受体的高竞争性和相对选择性的拮抗剂(pKi=10.4),并对人类神经肽Y4受体显示出拮抗效果(pEC50=8.6;pKi=9.6),同时是对人及大鼠神经肽YY2与Y5受体的弱激动剂。此外,GR231118对小鼠神经肽YY6受体具有较高亲和力(pKi=8.8)。 | |||
T36722 |
Deltorphin II (trifluoroacetate salt)
|
||
Deltorphin II is a peptide agonist of δ2-opioid receptors.1,2It is selective for δ-opioid receptors over μ- and κ-opioid receptors in radioligand bindings assays (Kis = 0.0033, >1, and >1 μM, respectively) and induces [35S]GTPγS binding in mouse brain membrane preparations (EC50= 0.034 μM). Deltorphin II (0.12 mg/kg) decreases the infarction zone:risk zone ratio in a rat model of myocardial ischemia-reperfusion injury induced by coronary occlusion, an effect that can be reversed by the δ2-opioid... | |||
T36679 |
Rp-cAMPS sodium salt
|
||
Rp-cAMPS sodium salt, a cAMP analog, is a potent, competitive cAMP-induced activation of cAMP-dependent PKA I and II (Kis of 12.5 μM and 4.5 μM, respectively) antagonist. Rp-cAMPS sodium salt is resistant to hydrolysis by phosphodiesterases[1][2][3][4][5][6]. A membrane-permeable competitive cAMP antagonist (Rp-cAMPS) that blocks PKA activation by binding to the regulatory subunits without dissociating the kinase holoenzyme also inhibits synaptic plasticity but has no effect on normal synaptic t... | |||
T35772 |
Emestrin
|
||
Emestrin is a mycotoxin originally isolated from E. striata that has antimicrobial, immunomodulatory, and cytotoxic activities.1,2,3,4,5 It is active against the fungi C. albicans and C. neoformans, as well as the bacteria E. coli, S. aureus, and methicillin-resistant S. aureus (MRSA; IC50s = 3.94, 0.6, 2.21, 4.55, and 2.21 μg/ml, respectively).2 Emestrin is a chemokine (C-C motif) receptor 2 (CCR2) antagonist (IC50 = 5.4 μM in a radioligand binding assay using isolated human monocytes).3 Emestr... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T35667 |
Napyradiomycin A1
Napyradiomycin A1 |
||
Napyradiomycin A1is a fungal metabolite originally isolated fromC. rubraand has diverse biological activities.1,2It is active againstS. aureus,M. luteus,B. anthracis,C. bovis, andM. smegmatis(MICs = 1.56-12.5 μg/ml).1Napyradiomycin A1is an estrogen receptor antagonist (IC50= 4.2 μM in rat uterine homogenates).2It also inhibits mitochondrial NADH:ubiquinone oxidoreductase (complex I) and succinate:ubiquinone oxidoreductase (complex II) activities in bovine heart homogenates (IC50s = 20 and 9.7 μM... |